A versatile synthetic approach to various 5-alkynyl modified isatin derivatives: Cytotoxicity, acetylcholinesterase inhibition activity and molecular modeling study; Bioorganic Chemistry; Vol. 165

书目详细资料
Parent link:Bioorganic Chemistry.— .— Amsterdam: Elsevier Science Publishing Company Inc.
Vol. 165.— 2025.— Article number 109038, 17 p.
其他作者: Cheremnykh K. P. Kirill, Ivanov I. D. Igor, Hamad M. S. Mohammad, Khlebnikov A. I. Andrey Ivanovich, Savelyev V. A. Victor, Pokrovsky M. A. Mikhail, Pokrovsky A. G. Andrey, Shults E. E. Elvira Eduardovna
总结:Title screen
Isatin derivatives have been of great interest in drug development research. 5-Alkynyl substituted isatin derivatives with anticancer potential and acetylcholinesterase inhibition (AChE) activity are designed and synthesized. The copper(I) catalyzed one-pot three-component reaction (AChauhan et al. (2021)3-coupling) of new 3-(1,3-dioxolane)-5-(ethynyl)isatins with formaldehyde and secondary amines or the Sonogashira cross-coupling reaction of C-3 protected iodoisatins with fluoro-N-(prop-2-ynyl)benzamide and prop-2-ynyl 4-fluorobenzoate were the main approaches for the synthesis of 5-(3-X-prop-1-yn-1-yl) substituted isatin derivatives (yield 53–87 %). 1-Benzyl-5-(prop-1-yn-1-yl)indoline-2,3-diones are smoothly formed by refluxing of 3-(1,3-dioxolane)-5-(propynyl)isatins in hydrochloric acid/MeOH (1:9, v/v). Results of in vitro biological assays (MTT-test) revealed that new 3-(1,3-dioxolane)-5-(3-X-prop-1-yn-1-yl)-1-benzylisatin derivatives are exhibited remarkable cytotoxicity against human cervical (C 33 A and CaSki), breast (MCF-7), prostate (DU-145) and glioblastoma (SNB-19 and T98G) cancer cell lines within low micromolar GI50 values. Additionally, all new compounds demonstrated relatively low cytotoxicity against the normal epithelial VERO cells (GI50 > 70 μM), indicating good selectivity. Moreover, the appropriate isatin derivatives displayed good and moderate acetylcholinesterase inhibition activity in vitro (Ellman’ s method) with IC50 up to 1.0–3.7 μM comparable to that for clinically used galantamine. Based on the results of in silico experiments the isatin derivatives bearing 5-(prop-1-yn-1-yl) substituents are promising for further search of acetylcholinesterase inhibitors in this series of compounds
Текстовый файл
AM_Agreement
语言:英语
出版: 2025
主题:
在线阅读:https://doi.org/10.1016/j.bioorg.2025.109038
格式: 电子 本书章节
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=684408